Comparison between population average and experimentally measured arterial input function in predicting biopsy results in prostate cancer.
about
Parameterizing the Logistic Model of Tumor Growth by DW-MRI and DCE-MRI Data to Predict Treatment Response and Changes in Breast Cancer Cellularity during Neoadjuvant Chemotherapy.A data-driven approach to prostate cancer detection from dynamic contrast enhanced MRI.Relative sensitivities of DCE-MRI pharmacokinetic parameters to arterial input function (AIF) scalingCurrent and future trends in magnetic resonance imaging assessments of the response of breast tumors to neoadjuvant chemotherapy.Techniques and applications of dynamic contrast enhanced magnetic resonance imaging in cancerQuantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validationCorrection of arterial input function in dynamic contrast-enhanced MRI of the liverAssessment of repeatability and treatment response in early phase clinical trials using DCE-MRI: comparison of parametric analysis using MR- and CT-derived arterial input functions.DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: pilot study findings.A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step towards practical implementation.A comparison of individual and population-derived vascular input functions for quantitative DCE-MRI in rats.Quantifying tumor vascular heterogeneity with dynamic contrast-enhanced magnetic resonance imaging: a review.Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer.Pharmacokinetic analysis based on dynamic contrast-enhanced MRI for evaluating tumor response to preoperative therapy for oral cancer.An improved coverage and spatial resolution--using dual injection dynamic contrast-enhanced (ICE-DICE) MRI: a novel dynamic contrast-enhanced technique for cerebral tumors.Dynamic contrast-enhanced magnetic resonance imaging of prostate cancer: A review of current methods and applications.Impact of arterial input function selection on the accuracy of dynamic contrast-enhanced MRI quantitative analysis for the diagnosis of clinically significant prostate cancer.Impact of precontrast T10 relaxation times on dynamic contrast-enhanced MRI pharmacokinetic parameters: T10 mapping versus a fixed T10 reference value.Automatic individual arterial input functions calculated from PCA outperform manual and population-averaged approaches for the pharmacokinetic modeling of DCE-MR images.
P2860
Q30639288-CD852B47-DC98-414B-A6AA-4607FF51EBDFQ30838603-BA420E86-47B6-41BB-AF7F-298D390EF3E9Q31107389-0807E7C0-6FA8-4BA8-8FC9-EC198670D51AQ34189855-E1276959-9A52-401A-B2A9-48CBBEAE5775Q35596205-8572F032-E455-4DC1-B628-7640E2AF5C1EQ35738413-1A0BC772-CBB5-4764-84AB-7D007DEFBF4CQ36020501-776FE627-9E3D-4AA1-AA2F-05C5559BD660Q36994280-7E540322-584E-45FE-B78E-8B679EDF763EQ37093041-A74C80F4-45F8-413E-9244-76FDB57A6D45Q37662706-481806E4-BB32-4903-B528-998D3FCC7680Q37662715-A024ABAB-38B9-46AD-BDB8-5D8D69DB7B6DQ37871859-D99B093A-9B66-4697-80BA-6C1D31CD2800Q38100740-94C9CEC3-2407-479A-B611-9CA44BCB9399Q45912968-9789987F-9D69-475B-B457-FF26F81D126EQ47389075-7B9076D2-0E9F-4E02-AF4D-F6B016042465Q49184459-A87377B7-2FC6-4A60-8E25-04EF30D935C4Q50863441-577DC632-1397-4501-8A98-9596DDBA6F53Q51129136-412B65A4-C8E7-436C-B6E8-DE6BD0A2C612Q53388852-19E76E74-1927-4701-9F5F-92A05C5CC3FE
P2860
Comparison between population average and experimentally measured arterial input function in predicting biopsy results in prostate cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Comparison between population ...... sy results in prostate cancer.
@en
type
label
Comparison between population ...... sy results in prostate cancer.
@en
prefLabel
Comparison between population ...... sy results in prostate cancer.
@en
P2093
P2860
P1433
P1476
Comparison between population ...... sy results in prostate cancer.
@en
P2093
Edward C Jones
Piotr Kozlowski
S Larry Goldenberg
Silvia D Chang
P2860
P304
P356
10.1016/J.ACRA.2009.11.006
P577
2010-01-13T00:00:00Z